Antitrust & Competition Policy Blog

Editor: D. Daniel Sokol
University of Florida
Levin College of Law

Tuesday, November 9, 2004

Pharmaceutical Antitrust Case in the News

Generic Line reports that Organon and its parent company, Akzo Nobel, entered into $ 36 million settlement with the AG's of all 50 states to resolve state antitrust claims stemming from anticompetitive acts related to its anti-depression drug Remeron.  The claims alleged that the two companies took steps to block the entry of generic competition, including fraudulent claims about its patents made to the FDA.

| Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Pharmaceutical Antitrust Case in the News:


Post a comment